Abstract Details
|
Yohannes W. Woldeamanuel, MD
(Mayo Clinic Arizona)
PRESENTER |
Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Atheneum. Dr. Woldeamanuel has received personal compensation in the range of $0-$499 for serving as a Consultant for Research Square. The institution of Dr. Woldeamanuel has received research support from NINDS. Dr. Woldeamanuel has a non-compensated relationship as a Chief Medical Officer, Co-Founder with Ex-Amplify Therapeutics that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Adjunct Faculty with Arizona State University that is relevant to Â鶹´«Ã½Ó³» interests or activities. Dr. Woldeamanuel has a non-compensated relationship as a Founder & Consultant with Advanced Clinical & Research Center that is relevant to Â鶹´«Ã½Ó³» interests or activities. |
| No disclosure on file | |
| Robert Cowan, MD, FÂ鶹´«Ã½Ó³» (Stanford Neurosciences Health Center) | Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Cowan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for lundbeck. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biohavenn. Dr. Cowan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbviie. Dr. Cowan has stock in Percept. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received intellectual property interests from a discovery or technology relating to health care. Dr. Cowan has received publishing royalties from a publication relating to health care. |
| Kathryn A. Giles, MD | No disclosure on file |